Targeted Innovation
Mechanism of Action & Differentiation
A precision-driven approach to targeting mitochondrial function in cancer cells, addressing a critical driver of tumor survival and progression.
Our differentiated mechanism selectively disrupts tumor metabolism, inducing apoptosis through intrinsic pathways while preserving the integrity of healthy cells.
This strategy enables enhanced therapeutic selectivity, improved safety, and the potential for more durable clinical outcomes.
Broad cytosolic inhibition leads to protein degradation and systemic toxicity.
How GAM-05 kills Cancer Cell?
Disrupts Mitochondrial Integrity
Target Oxidative Phosphorylation
Counter Proteins Promoting Cell Death Resistance
Gam-05 Design
- Gam-05 is a rationally engineered conjugate combining:
- An inhibitory moiety
- A mitochondrial-targeting vector
- This design physically directs the drug to mitochondria.
Key Differentiation
- Confirmed mitochondrial localization (high mitochondria/cytosol ratio)
- No inhibition of cytosolic Hsp, preserving normal protein homeostasis
- Avoidance of the heat-shock response